In Brief: Citi Pharmaceuticals Friatroy
This article was originally published in The Tan Sheet
Executive Summary
Citi Pharmaceuticals Friatroy: Herbal product is being distributed with claims for, among other things, tumor mass reduction, decrease in tumor markets, decrease in asthenia (weakness or loss of strength), reduction in pain and as a diuretic, FDA states in a Jan. 16 warning letter to the Miami-based firm. Citi published ads for conferences/seminars that state that "doctors will speak about Friatroy for the treatment of cancer and HIV/AIDS," FDA notes, making the product an unapproved drug for those diseases...